FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS

Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients. The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of ACE in...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awdur: Yu. M. Lopatin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Cyfres:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Pynciau:
high cardio-vascular risk
ramipril
telmisartan
норе trial
ontarget trial
Mynediad Ar-lein:https://www.rpcardio.com/jour/article/view/1052
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg